From the Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute, University of Pittsburgh, PA (M.L., D.G.).
Division of Cardiology, University of Pittsburgh School of Medicine, PA (M.L., D.G.).
Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):1715-1723. doi: 10.1161/ATVBAHA.119.312131. Epub 2019 Jul 25.
Vascular smooth muscle cells (SMC) play a critical role in controlling blood pressure and blood distribution, as well as maintaining the structural integrity of the blood vessel. SMC also participate in physiological and pathological vascular remodeling due to their remarkable ability to dynamically modulate their phenotype. During the past decade, the development of in vivo fate mapping systems for unbiased identification and tracking of SMC and their progeny has led to major discoveries as well as the reevaluation of well-established concepts about the contribution of vascular SMC in major vascular diseases including atherosclerosis. Lineage tracing studies revealed that SMC undergoes multiple phenotypic transitions characterized by the expression of markers of alternative cell types (eg, macrophage-like and mesenchymal-stem cell-like) and populate injured or diseased vessels by oligoclonal expansion of a limited number of medial SMC. With the development of high-throughput transcriptomics and single-cell RNA sequencing (scRNAseq), the field is moving forward towards in-depth SMC phenotypic characterization. Herein, we review the major observations put forth by lineage and clonality tracing studies and the evidence in support for SMC phenotypic diversity in healthy and diseased vascular tissue. We will also discuss the opportunities and remaining challenges of combining lineage tracing and single-cell transcriptomics technologies, as well as studying the functional relevance of SMC phenotypic transitions and identifying the mechanisms controlling them.
血管平滑肌细胞(SMC)在控制血压和血液分布以及维持血管结构完整性方面发挥着关键作用。SMC 还参与生理和病理血管重塑,因为它们具有动态调节其表型的显著能力。在过去的十年中,用于无偏鉴定和跟踪 SMC 及其前体细胞的体内命运映射系统的发展带来了重大发现,并重新评估了关于血管 SMC 在包括动脉粥样硬化在内的主要血管疾病中的贡献的既定概念。谱系追踪研究表明,SMC 经历了多种表型转变,其特征是表达替代细胞类型的标志物(例如,巨噬细胞样和间充质干细胞样),并通过有限数量的中膜 SMC 的寡克隆扩增填充受伤或患病的血管。随着高通量转录组学和单细胞 RNA 测序(scRNAseq)的发展,该领域正在朝着深入的 SMC 表型特征分析方向发展。在此,我们回顾了谱系和克隆追踪研究提出的主要观察结果,以及支持健康和患病血管组织中 SMC 表型多样性的证据。我们还将讨论结合谱系追踪和单细胞转录组学技术的机会和剩余挑战,以及研究 SMC 表型转变的功能相关性并确定控制它们的机制。